The clinical effect of intravesical instillation of chemotherapy immediately after transurethral resection of bladder tumours (TURBT) has recently been questioned, despite its recommendation in guidelines. Our aim was to compare TURBT alone with immediate post-TURBT intravesical passive diffusion (PD) of mitomycin and immediate pre-TURBT intravesical electromotive drug administration (EMDA) of mitomycin in non-muscle invasive bladder cancer.
DI STASI, S.m., Valenti, M., Verri, C., Liberati, E., Giurioli, A., Leprini, G., et al. (2011). Electromotive instillation of mitomycin immediately before transurethral resection for patients with primary urothelial non-muscle invasive bladder cancer: a randomised controlled trial. THE LANCET ONCOLOGY, 12(9), 871-879 [10.1016/S1470-2045(11)70190-5].
Electromotive instillation of mitomycin immediately before transurethral resection for patients with primary urothelial non-muscle invasive bladder cancer: a randomised controlled trial
DI STASI, SAVINO MAURO;MICALI, FRANCESCO;VESPASIANI, GIUSEPPE
2011-09-01
Abstract
The clinical effect of intravesical instillation of chemotherapy immediately after transurethral resection of bladder tumours (TURBT) has recently been questioned, despite its recommendation in guidelines. Our aim was to compare TURBT alone with immediate post-TURBT intravesical passive diffusion (PD) of mitomycin and immediate pre-TURBT intravesical electromotive drug administration (EMDA) of mitomycin in non-muscle invasive bladder cancer.| File | Dimensione | Formato | |
|---|---|---|---|
|
LANCET_ONCOL_2011_12_871-879.pdf
accesso aperto
Licenza:
Copyright dell'editore
Dimensione
189.7 kB
Formato
Adobe PDF
|
189.7 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
